TMX VettaFi has Acquired iNDEX Research
Read more
Indexing
Indexes
Featured
Energy
Robotics & AI
Overview
Benchmarks
Factor
Thematics
All indexes
What we do
Index licensing
Design & customization
Calculation & administration
Indexes
What we do
Services
Indexing
Overview
Index licensing
Design & customization
Calculation & administration
Platform
Digital marketing
Overview
Display ads
Custom content
Lead generation
Data & analytics
Overview
Lead subscription
Web traffic tracking
Event sponsorship
Advisor resources
Indexing
Platform
Digital marketing
Data & analytics
Event sponsorship
Advisor resources
Insights
Company
About us
Get VettaFi’ed
VettaFi Voices
Announcements
About us
Get VettaFi’ed
VettaFi Voices
Announcements
Let’s connect
Let’s connect
Search
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Indexing
Medical and Healthcare
THINR
VettaFi Weight Loss Drug & Treatment Index
Quick Links
Methodology
Fact Sheet
Top Constituents
Chart view
Table view
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Index Level
3-Month
6-Month
1-Year
YTD
Price Return
Index level
2,429.6
3-Month
9.5%
6-Month
4.7%
1-Year
-25.2%
5-Year
-8.9%
As of May 02, 2022
ON THIS PAGE
Overview
Tickers
Characteristics
Resources
Composition
Top constituents
Linked products
Insights
Fact Sheet
Methodology
Quick Links
Methodology
Fact Sheet
Top Constituents
Overview
An index of global companies manufacturers in the GLP-1 pharmaceuticals business or who enable the business. The index allocates 70% of its weight to a Principal Manufacturers segment and 30% to an Enablers segment.
Asset class
Equity
Category
Thematic
No items found.
Family
Medical and Healthcare
Region
Global
Rebalance frequency
Quarterly
Tickers
Price return
THINR
Total return
THINRT
Net total return
THINRN
Characteristics
Number of constituents
29
Market capitalization
$2.62 Trillon
Adjusted market capitalization
$2.53 Trillon
Dividend yield
1.45%
Resources
Methodology
VettaFi Weight Loss Drug Index Methodology
Research
Investment Case for THINR
Research
VettaFi Overview and Index Research - THINR May 2024
Composition
Sectors
Countries / Regions
Category
Some index
12%
Top constituents
As of
November 5, 2024
Ticker
Company Name
ISIN
Weight
Ticker
Company Name
Company Name
ISIN
US30231G1022
Weight
10.8%
Ticker
Company Name
Company Name
ISIN
US30231G1022
Weight
10.8%
Ticker
Company Name
Company Name
ISIN
US30231G1022
Weight
10.8%
Ticker
Company Name
Company Name
ISIN
US30231G1022
Weight
10.8%
Ticker
Company Name
Company Name
ISIN
US30231G1022
Weight
10.8%
Ticker
Company Name
Company Name
ISIN
US30231G1022
Weight
10.8%
Ticker
Company Name
Company Name
ISIN
US30231G1022
Weight
10.8%
Ticker
Company Name
Company Name
ISIN
US30231G1022
Weight
10.8%
Ticker
Company Name
Company Name
ISIN
US30231G1022
Weight
10.8%
Ticker
Company Name
Company Name
ISIN
US30231G1022
Weight
10.8%
Showing
0
to
99
of
300
entries
1
...
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Linked products
Ticker
Product name
ISIN
Licensee
THNR
Product name
Amplify Weight Loss Drug & Treatment ETF
ISIN
US30231G1022
Licensee
Amplify
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Insights
THINR Investing in GLP-1
Learn more
Link
Read more
Sign up for index updates to stay in the know.
By clicking submit, you’re opting into communications, subject to our
Privacy Policy.
By clicking submit, you’re opting into communications, subject to our
Privacy Policy.
Interested in market data packages?
Contact our team for more information.
Thank you! Your submission has been received!
By clicking submit, you’re opting into communications, subject to our
Privacy Policy.
No items found.
